Methanesulfonic acid methyl 2-imino-3-methyl-2,3-dihydro-1,3-benzothiazole-6-carboxylate
CAS : 2034455-56-4
Ref. 3D-JGD45556
| 1g | Arrêté | ||
| 50mg | Arrêté | ||
| 100mg | Arrêté | ||
| 250mg | Arrêté | ||
| 500mg | Arrêté |
Informations sur le produit
Nom :
Methanesulfonic acid methyl 2-imino-3-methyl-2,3-dihydro-1,3-benzothiazole-6-carboxylate
Description :
Methanesulfonic acid methyl 2-imino-3-methyl-2,3-dihydro-1,3-benzothiazole-6-carboxylate (MSI) is a derivative of imatinib and has been used in the treatment of cancer. MSI is a reactive compound that can form hydrogen bonds with other compounds. It has been shown to have an acidic pH of 1.0 in water vapor. MSI also has an absorption maximum at 280 nm due to the presence of a trifluoromethanesulfonic acid group. MSI crystallizes into different polymorphs depending on the conditions under which it is purified, including amorphous and crystalline solids. The particle size distribution for these polymorphs ranges from 0.1 to 5 microns, with an average particle size of 1 micron.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
318.4 g/mol
Formule :
C11H14N2O5S2
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
